3.13 USD
▲-0.03+4.17%
盘后 3.01 +0.33%
2026-08-03
市值
$188.82M
市盈率
—
EPS
-1.98
股息率
—
52 周区间
2.88 – 5.55
成交量
429.01K
Beta
1.31
目标价
14.89
52W 低 2.8852W 高 5.55
价格走势
公司简介
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer’s disease. The company also provides research program for the treatment of Huntington’s disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small mo...